Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Profound Medical (PROF) Operating Expenses (2023 - 2025)

Historic Operating Expenses for Profound Medical (PROF) over the last 3 years, with Q3 2025 value amounting to $12.8 million.

  • Profound Medical's Operating Expenses rose 1908.03% to $12.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $52.6 million, marking a year-over-year increase of 3626.09%. This contributed to the annual value of $40.1 million for FY2024, which is 2164.85% up from last year.
  • According to the latest figures from Q3 2025, Profound Medical's Operating Expenses is $12.8 million, which was up 1908.03% from $15.4 million recorded in Q2 2025.
  • In the past 5 years, Profound Medical's Operating Expenses registered a high of $15.4 million during Q2 2025, and its lowest value of $7.5 million during Q2 2023.
  • For the 3-year period, Profound Medical's Operating Expenses averaged around $10.4 million, with its median value being $9.8 million (2023).
  • Its Operating Expenses has fluctuated over the past 5 years, first soared by 859.52% in 2024, then soared by 6651.19% in 2025.
  • Profound Medical's Operating Expenses (Quarter) stood at $9.8 million in 2023, then grew by 15.31% to $11.3 million in 2024, then increased by 13.59% to $12.8 million in 2025.
  • Its Operating Expenses stands at $12.8 million for Q3 2025, versus $15.4 million for Q2 2025 and $13.0 million for Q1 2025.